Live Data keeps real-time information on employment status
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Mercado: Will more excitement find the Central Coast before 2025?
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne beats second-quarter estimates
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Engineer spearheads new desalination tech in Moorpark
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latigo taps Farzan for CEO post
The common saying goes “The third time’s a charm” but for Nima Farzan, he’s looking to go 3-for-3 successfully running biotechnology companies. On July 22, Farzan was appointed to be Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, first CEO. Farzan’s experience spans more than two decades long in the biopharmaceutical industry, including being the Read More →
Thousand Oaks biotech company appoints CEO
Latigo Biotherapeutics, a clinical-stage biotech company based in Thousand Oaks, announced that it has appointed Nima Farzan to be its CEO. Announced July 22, Farzan brings a “strong track record” with more than two decades of leadership experience in the biopharmaceutical industry. Farzan is also Latigo’s first CEO as he replaces Desmond Padhi, operating partner Read More →
Novocuff raises $26M to address preterm births
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
